Kornitzer Capital Management Inc. KS purchased a new stake in shares of Carlsmed, Inc. (NASDAQ:CARL – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. Get Carlsmed alerts:Analysts Set New Price TargetsA number of research analysts recently issued reports on CARL shares. BTIG Research reissued a “buy” rating and set a $24.00 price target on shares of Carlsmed in a research note on Monday, December 15th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Carlsmed (NASDAQ:CARL – Get Free Report) last issued its earnings results on Thursday, November 6th.